Lemaitre Vascular (LMAT) stock price, chart and financials
Price chart
Financials
- Revenue (quarter)
- $70.4M
- Gross margin
- 72.90%
- Net income (quarter)
- $17.1M
- Net margin
- 25.02%
- Return on equity
- 16.77%
- Book value per share
- $18.38
- Price to book
- 4.58
- Debt to assets
- 34.38%
- Payout ratio
- 31.34%
- Dividend yield
- 1.13%
Company profile
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Frequently asked questions
Is Lemaitre Vascular (LMAT) profitable?
Yes. Lemaitre Vascular earned $65.7M in net income over the trailing twelve months, a net margin of 25.02%.
How much revenue does Lemaitre Vascular (LMAT) make?
Lemaitre Vascular generated $262.4M in revenue over the trailing twelve months, up 9.57% year over year.
What is LMAT's P/E ratio?
Lemaitre Vascular trades at 29.3 times trailing twelve-month earnings, on an EPS of $2.88.
How do I buy stock in Lemaitre Vascular (LMAT)?
LMAT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
